Explore evidence

97.8 %Of 1691 key populations living with HIV who had a viral load test, 97.8% (n = 1654) were virally suppressed (viral load ≤1000 copies/mL).

NigeriaVIH/sidapublished 2021PloS onePubMeddocument of 7 observations

84 %The discontinuation rate of PrEP was 84% among HIV-negative individuals who initiated PrEP in two large-scale HIV programs in Akwa Ibom and Cross River states in Nigeria between January 2020 and July 2021.

NigeriaVIH/sidaobserved January 2020 to July 2021published 2024BMC public healthPubMeddocument of 2 observations

41.8 %Only 41.8% of male senior secondary school students in Lagos, Nigeria knew where HIV Testing Services were offered.

NigeriaVIH/sidapublished 2019West African journal of medicinePubMeddocument of 7 observations

5,103 casesAmong 204,930 participants aged ≥18 months in the Nigeria AIDS Indicator and Impact Survey (NAIIS) 2018, 5,103 were reactive on test 1 (Determine HIV-1/2).

NigeriaVIH/sidaobserved 2018published 2022PLOS global public healtheurope_pmcdocument of 10 observations

5.7 %Stigma was cited as a reason for antiretroviral therapy non-adherence in 24 cases (5.7%) among female sex workers who died from HIV/AIDS.

NigeriaVIH/sidaobserved 2022-02-01 to 2023-02-28published 2026International journal of environmental research and public healthPubMeddocument of 10 observations

19.1 %The prevalence of tuberculosis (TB) and human immunodeficiency virus (HIV) coinfection in Nigeria is currently around 19.1%.

Nigeriatuberculose · VIH/sidapublished 2022Microbiology spectrumPubMeddocument of 6 observations

96.2 %Viral suppression improved from 73.5% to 96.2% between the pre-surge and post-surge periods in Akwa Ibom State, Nigeria.

NigeriaVIH/sidapublished 2022PloS onePubMeddocument of 7 observations

HIV-1 subtype analysis revealed the predominance of CRF02_AG and subtype G in the study population.

NigeriaCRF02_AG · subtype G · VIH/sidapublished 2022AIDS (London, England)PubMeddocument of 4 observations

70 %Among 57 HIV-infected, HIV-exposed infants in Plateau State, Nigeria, 70% (40/57) had favorable treatment outcomes.

NigeriaVIH/sidaobserved 2018–2022published 2026PloS onePubMeddocument of 13 observations

54 %Among people living with HIV in the African Cohort Study from 2013 through 2020, causes of death were ascertained in 54% of participants.

NigeriaVIH/sidaobserved 2013 through 2020published 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations

70.6 %Of the 17 health facilities assessed in Abuja, Nigeria between February and May 2017, 12 (70.6%) provided nutritional support for people living with HIV/AIDS.

NigeriaVIH/sidaobserved February and May 2017published 2021The Pan African medical journalPubMeddocument of 6 observations

69.4 %Among aging people living with HIV (PLWH) in Ibadan, Nigeria, the prevalence of any multimorbidity was 69.4%.

NigeriaVIH/sidaobserved 2018published 2020AIDS research and human retrovirusesPubMeddocument of 3 observations

220 /μLIn the pre-fee cohort, the median baseline CD4 count was 220/μL, compared to 222/μL in the post-fee cohort.

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 9 observations

18.3 %HIV positivity was found in 37 out of 202 (18.3%) tuberculosis patients in the North Central zone of Nigeria.

Nigeriatuberculose · VIH/sidapublished 2019Journal of epidemiology and global healthPubMeddocument of 7 observations

8.05 scoreThe mean OHIP-14 score among HIV-positive patients in Nigeria was 8.05 with a standard deviation of 9.54.

NigeriaVIH/sidapublished 2021African health sciencesPubMeddocument of 5 observations

5.61 aORBeing a woman or girl on the move living with HIV was associated with experiencing more gender-based violence since COVID-19 started (adjusted odds ratio 5.61, 95% CI 3.01 to 10.47).

NigeriaVIH/sidapublished 2023BMJ global healthPubMeddocument of 5 observations

30 %Among 219 men who have sex with men (MSM) in Nigeria enrolled in the TRUST-PrEP study, only 66/219 (30%) had at least one record of protective serum tenofovir concentration (≥ 4.2 ng/mL).

NigeriaVIH/sidaobserved April 2018 to May 2019published 2023PloS onePubMeddocument of 5 observations

0 %HIV positivity rate at the immunization clinic was 0%.

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 16 observations

25.4 %More females (25.4%) compared to males (20.8%) among adolescents and young adults (AYA) in Nigeria had ever tested for HIV.

NigeriaVIH/sidaobserved 2017published 2020PloS onePubMeddocument of 4 observations

94.1 %Of the 17 health facilities assessed in Abuja, Nigeria between February and May 2017, 16 (94.1%) had well-established referral services for people living with HIV/AIDS.

NigeriaVIH/sidaobserved February and May 2017published 2021The Pan African medical journalPubMeddocument of 6 observations

95.4 %Viral suppression rate among adults enrolled in differentiated service delivery models was 95.4% compared to 91.8% among those in standard care, with a p-value less than 0.01.

NigeriaVIH/sidapublished 2021Journal of the International AIDS SocietyPubMeddocument of 6 observations

52.5 %Non-adherence to antiretroviral therapy was reported in 456 participants (52.5%).

NigeriaVIH/sidapublished 2026BMC public healthPubMeddocument of 8 observations

1.5 aORAdolescents and young adults in the 'consent and proximity' class were more likely to report transactional sex (adjusted odds ratio 1.50, 95% confidence interval 1.23–1.84).

NigeriaVIH/sidaobserved 2018published 2024PloS onePubMeddocument of 15 observations

274 casesAmong 16,727 female sex workers on antiretroviral therapy in Nigeria between 1 January 2016 and 31 August 2022, 274 (2%) had stopped ART by 31 August 2022.

NigeriaVIH/sidaobserved 2016-01-01 to 2022-08-31published 2026BMC women's healthPubMeddocument of 11 observations

0.5 %The prevalence of HCV infection was 0.5% among HIV-naïve children in Lagos.

Nigeriahépatite C · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations